Select your localized edition:

Close ×

More Ways to Connect

Discover one of our 28 local entrepreneurial communities »

Be the first to know as we launch in new countries and markets around the globe.

Interested in bringing MIT Technology Review to your local market?

MIT Technology ReviewMIT Technology Review - logo

 

Unsupported browser: Your browser does not meet modern web standards. See how it scores »

{ action.text }

Those interested in truly understanding the potential bioterror dangers of the emerging field of synthetic biology should make sure they read and keep updated on the discussion surrounding the Declaration of the Second International Meeting on Synthetic Biology. In this statement, which resulted from a conference attended by some 300 researchers, lawyers, and government policy types, experts in synthetic biology spelled out realistic concerns and suggested ways to go forward.

Also worth tracking is the controversy in the synthetic biology community over a newspaper article in The Guardian that led off with the teaser: “DNA sequences from some of the most deadly pathogens known to man can be bought over the Internet, the Guardian has discovered.” A well-argued critique by Rob Carlson can be found at his website.

On Wednesday, Technologyreview.com will run a Q&A with Drew Endy, a biological engineer at MIT and leading proponent of synthetic biology, asking him about these debates and how to safely proceed with synthetic biology research.

1 comment. Share your thoughts »

Reprints and Permissions | Send feedback to the editor

From the Archives

Close

Introducing MIT Technology Review Insider.

Already a Magazine subscriber?

You're automatically an Insider. It's easy to activate or upgrade your account.

Activate Your Account

Become an Insider

It's the new way to subscribe. Get even more of the tech news, research, and discoveries you crave.

Sign Up

Learn More

Find out why MIT Technology Review Insider is for you and explore your options.

Show Me